INVESTINGState Attorneys General Sue Generic Drugmakers for Inflating PricesBy Dan WeilJun 10, 2020 12:25 PM EDT
PRESS RELEASESTeva Announces New Drug Application Filing In Japan For AJOVY® (fremanezumab) InjectionBy Business WireJul 29, 2020 8:00 AM EDT
PRESS RELEASESPhathom Pharmaceuticals Announces Appointment Of Todd Branning As Chief Financial OfficerBy GlobeNewswireJul 13, 2020 8:30 AM EDT
PRESS RELEASESTeva Announces Availability Of ProAir® Digihaler® (albuterol Sulfate 117 Mcg) Inhalation Powder For Patients With Asthma And COPDBy Business WireJul 13, 2020 8:00 AM EDT
PRESS RELEASESTeva To Host Conference Call To Discuss Second Quarter 2020 Financial Results At 8 A.m. ET On August 5, 2020By Business WireJul 9, 2020 4:00 PM EDT
PRESS RELEASESTeva To Present New Data On AJOVY® (fremanezumab-vfrm) Injection Open-Label Extension Study At American Headache Society Annual MeetingBy Business WireJun 15, 2020 8:00 AM EDT
INVESTINGState Attorneys General Sue Generic Drugmakers for Inflating PricesBy Dan WeilJun 10, 2020 12:25 PM EDT
JIM CRAMERNew Market: Cramer's 'Mad Money' Recap (Thursday 5/28/20)By Scott RuttMay 28, 2020 8:58 PM EDT
PRESS RELEASESTeva Announces Virtual 2020 Annual Meeting Of ShareholdersBy Business WireMay 26, 2020 8:00 AM EDT
PRESS RELEASESTeva To Present New AJOVY® (fremanezumab) Analyses And Latest COPAXONE® Data (glatiramer Acetate Injection) At European Academy Of Neurology CongressBy Business WireMay 22, 2020 2:00 AM EDT
PRESS RELEASESChina Approves AUSTEDO® For Treating Chorea Associated With Huntington's Disease And Tardive Dyskinesia In AdultsBy Business WireMay 18, 2020 7:00 AM EDT
INVESTINGBuffett Exits Phillips 66 and Travelers, Trims Goldman SachsBy Tom BemisMay 15, 2020 7:37 PM EDT
INVESTINGTeva Soars as Generic Drugmaker Tops Earnings and Revenue EstimatesBy Scott Van VoorhisMay 7, 2020 9:07 AM EDT
PRESS RELEASESNew Data For Teva AJOVY® (fremanezumab-vfrm) Injection And AUSTEDO® (deutetrabenazine) Tablets Included In NeurologyBy Business WireMay 1, 2020 8:00 AM EDT
PRESS RELEASESTeva To Host Conference Call To Discuss First Quarter 2020 Financial Results At 8 A.m. ET On May 7, 2020By Business WireApr 16, 2020 6:27 PM EDT
HEALTHCoronavirus Latest Updates: A Timeline of Recent EventsBy Steve FiorilloMar 30, 2020 12:05 PM EDT
INVESTINGTeva Donates 6 Million Tablets of Malaria Drug to Fight Coronavirus in U.S.By Dan WeilMar 20, 2020 10:44 AM EDT
PRESS RELEASESTeva To Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets To Hospitals NationwideBy Business WireMar 19, 2020 8:23 PM EDT
PRESS RELEASESPositive Recommendation By NICE For First Anti-CGRP Migraine Therapy: AJOVY®▼ (fremanezumab)By Business WireMar 12, 2020 3:30 AM EDT
PRESS RELEASESTeva Announces FDA Approval Of ArmonAir® Digihaler™ (fluticasone Propionate) Inhalation PowderBy Business WireFeb 24, 2020 8:00 AM EST
PRESS RELEASESTeva Announces Registration Trials Of Deutetrabenazine In Pediatric Patients With Tourette Syndrome Did Not Meet The Primary EndpointBy Business WireFeb 19, 2020 4:05 PM EST
INVESTINGWarren Buffett’s Berkshire Hathaway Takes Stakes in Kroger, Biogen; Cuts Banks and AppleBy Tom BemisFeb 14, 2020 7:58 PM EST
INVESTINGTeva Pharmaceutical Jumps After Earnings Meet Wall Street EstimatesBy M. Corey GoldmanFeb 12, 2020 9:41 AM EST
